HomeACE • STO
add
Ascelia Pharma AB
Previous close
kr 3.21
Day range
kr 3.13 - kr 3.28
Year range
kr 2.31 - kr 5.23
Market cap
402.17M SEK
Avg Volume
1.10M
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 15.25M | -14.27% |
Net income | -15.67M | 27.88% |
Net profit margin | — | — |
Earnings per share | -0.13 | 69.05% |
EBITDA | -15.23M | 14.28% |
Effective tax rate | 0.32% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 72.28M | -24.49% |
Total assets | 136.42M | -15.48% |
Total liabilities | 22.01M | -59.10% |
Total equity | 114.40M | — |
Shares outstanding | 117.47M | — |
Price to book | 3.30 | — |
Return on assets | -29.14% | — |
Return on capital | -35.06% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -15.67M | 27.88% |
Cash from operations | -15.66M | 8.13% |
Cash from investing | — | — |
Cash from financing | 27.50M | -66.92% |
Net change in cash | 11.83M | -82.06% |
Free cash flow | -10.96M | -3,043.65% |
About
Founded
1999
Website
Employees
11
